Dyne Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DYN and other ETFs, options, and stocks.About DYN
Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph.
CEOJohn G. Cox
CEOJohn G. Cox
Employees191
Employees191
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2017
Founded2017
Employees191
Employees191
DYN Key Statistics
Market cap3.22B
Market cap3.22B
Price-Earnings ratio-5.34
Price-Earnings ratio-5.34
Dividend yield—
Dividend yield—
Average volume4.55M
Average volume4.55M
High today$19.87
High today$19.87
Low today$19.06
Low today$19.06
Open price$19.33
Open price$19.33
Volume3.15M
Volume3.15M
52 Week high$26.69
52 Week high$26.69
52 Week low$6.36
52 Week low$6.36
Stock Snapshot
As of today, Dyne Therapeutics(DYN) shares are valued at $19.87. The company's market cap stands at 3.22B, with a P/E ratio of -5.34.
On 2025-12-16, Dyne Therapeutics(DYN) stock moved within a range of $19.06 to $19.87. With shares now at $19.87, the stock is trading +4.2% above its intraday low and 0.0% below the session's peak.
Trading activity shows a volume of 3.15M, compared to an average daily volume of 4.55M.
The stock's 52-week range extends from a low of $6.36 to a high of $26.69.
The stock's 52-week range extends from a low of $6.36 to a high of $26.69.
Analyst ratings
88%
of 16 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own DYN. This list is generated using Robinhood data, and it’s not a recommendation.